Nasdaq Markets

Image source: The Motley Fool.

Image source: The Motley Fool.

Image source: The Motley Fool.

Image source: The Motley Fool.

(RTTNews) - Indian shares are likely to open a tad higher on Tuesday after oil prices fell sharply overnight on concerns about the global economy and the outlook for energy demand due to the coronavirus outbreak, which has infected more than 40,600 people globally.

Image source: The Motley Fool.

Image source: The Motley Fool.

Image source: The Motley Fool.

Image source: The Motley Fool.

(RTTNews) - The Indonesia stock market on Monday halted the four-day winning streak in which it had advanced almost 110 points or 1.9 percent. The Jakarta Composite Index now rests just above the 5,950-point plateau although it may bounce higher again on Tuesday.

In an effort by Illinois to level the playing field for its the rapidly growing legal cannabis market, the state's Department of Financial and Professional Regulation is allowing medical marijuana dispensaries to stay open later.

(RTTNews) - The Australian stock market is advancing on Tuesday following the overnight gains on Wall Street and on some positive corporate earnings results.

(RTTNews) - The Hong Kong stock market has moved lower in three straight sessions, surrendering more than 540 points or 2 percent along the way. The Hang Seng Index now rests just above the 27,240-point plateau although it may stop the bleeding on Tuesday.

(RTTNews) - The China stock market has climbed higher in five straight sessions, advancing more than 145 points or 5 percent along the way. The Shanghai Composite Index now rests just above the 2,890-point plateau and it may add to its winnings again on Tuesday.

(RTTNews) - Responding to Chatham Asset Management's letter, R.R. Donnelley & Sons Co. (RRD) said that stockholder rights plan does not inhibit Chatham's dialogue with RRD.

Johnson & Johnson (NYSE: JNJ) subsidiary Janssen announced on Monday that it had filed a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for its multiple myeloma drug Darzalex (also known as daratumumab).

Perceptron (PRCP) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.

Blackbaud (BLKB) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.65 per share a year ago. These figures are adjusted for non-recurring items.

II-VI (IIVI) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.71 per share a year ago. These figures are adjusted for non-recurring items.

Rapid7 (RPD) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items.